Royal Philips , a global leader in health technology, announced the debut of EarlyVue VS30, a new vital signs monitor, in the U.S. Expanding on Philips’ General Care solutions portfolio, Philips EarlyVue VS30 uses automated Early Warning Scoring (EWS) to collect critical vital signs and calculate risk-based alerts that allow clinicians to identify subtle signs of patient deterioration. With this point-of-care alert capability, clinicians in general care settings can facilitate communication between caregivers for timely intervention and patient care.
The growing number of older, sicker patients, combined with the higher patient-to-clinician ratio on general care floors, pose a continuing challenge for clinicians to care for their patients proactively and efficiently. Clinicians are struggling with high workloads, job dissatisfaction and health issues resulting from work-related stress, associated with a high intention to leave their current job or the nursing field altogether.
In fact, a recent U.S. review published in the International Journal of Nursing Sciences reported a nursing turnover rate as high as 27%. When high demands in care coincide with a shortage in staff, the resulting environment could compromise patient care. With the clinician bandwidth challenges, there has been an error rate of up to 15 percent associated with recording vital signs on paper and transferring to the EMR.
With its connectivity capability, the EarlyVue VS30 monitor allows clinicians to view vitals at the bedside or remotely through a new monitor-to-monitor data sharing feature. Designed to create new workflow efficiencies, the VS30 captures patient data and securely transmits it directly into the hospital’s EMR to help reduce errors and support gap-free patient records to help improve patient outcomes.
“With preventable patient adverse events and clinical workflow issues on the rise, it’s imperative that the healthcare industry looks for ways to alleviate these challenges,” said Peter Ziese, business leader of Monitoring and Analytics at Philips. “Integrated technology with smart algorithms, like EarlyVue VS30, can benefit both clinicians and patients by limiting transcription errors and providing early risk-based alerts for timely interventions – allowing clinicians to, confidently and proactively deliver care.”
The EarlyVue VS30 monitor has received 510(k) clearance from the FDA and is available for sale in the U.S. Additional information on Philips’ full suite of integrated patient monitoring solutions is available here.
About Royal Philips
Royal Philips is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2018 sales of EUR 18.1 billion and employs approximately 80,000 employees with sales and services in more than 100 countries.